Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab for Surgical Treatment of Severe PDR
NCT01025934Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of bevacizumab in proliferative diabetic retinopathy (PDR), sponsored by University of Campania Luigi Vanvitelli. Status: completed.
02
Drugs
bevacizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT01025934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025934.